{
    "title": "103_hr2640",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Health Care Cooperative Antitrust \nProtection Act of 1993''.\n\nSEC. 2. PURPOSE.\n\n    It is the purpose of this Act to substantively encourage the \nformation of efficiency producing, pro-competitive joint ventures among \nproviders of health care services by minimizing unnecessary antitrust \nrisk and clarifying regulatory ambiguity in order to reduce excess \ncapacity and duplication of services.\n\nSEC. 3. DEFINITIONS.\n\n    For purposes of this Act:\n            (1) The term ``Advisory Committee'' means the Interagency \n        Advisory Committee on Competition, Antitrust Policy, and Health \n        Care established under section 6.\n            (2) The term ``antitrust laws'' has the meaning given it in \n        subsection (a) of the first section of the Clayton Act (15 \n        U.S.C. 12(a)), except that such term includes--\n                    (A) section 5 of the Federal Trade Commission Act \n                (15 U.S.C. 45) to the extent such section applies to \n                unfair methods of competition; and\n                    (B) any State law similar to the laws referred to \n                in subparagraph (A).\n            (3) The term ``health care joint venture'' means an \n        agreement between 2 or more providers of health care services \n        that is entered into solely for the purpose of sharing in the \n        provision of health care services and that involves substantial \n        integration or financial risk-sharing between the parties, but \n        does not include the exchanging of information, the entering \n        into of any agreement, or the engagement in any other conduct \n        that is not reasonably required to carry out such agreement.\n            (4) The term ``health care services'' includes services \n        related to the delivery or administration of health care \n        services.\n            (5) The term ``provider of health care services'' means any \n        individual or entity that is engaged in the delivery of health \n        care services in a State and that is required by State law or \n        regulation to be licensed or certified by the State to engage \n        in the delivery of such services in the State.\n            (6) The term ``Secretary'' means the Secretary of Health \n        and Human Services.\n\nSEC. 4. ESTABLISHMENT OF EXEMPTION PROGRAM FOR HEALTH CARE JOINT \n              VENTURES.\n\n    (a) Establishment.--\n            (1) In general.--Not later than 6 months after the date of \n        the enactment of this Act, the Secretary of Health and Human \n        Services, in concurrence with the Attorney General, shall \n        promulgate specific guidelines under which a health care joint \n        venture may submit an application requesting that the Secretary \n        provide the entities participating in the joint venture with \n        either of the following exemptions:\n                    (A) With respect to any action brought against the \n                entity under the antitrust laws, an exemption under \n                which (notwithstanding any other provision of law)--\n                            (i) monetary recovery on a claim shall be \n                        limited to actual damages if the claim results \n                        from conduct within the scope of the joint \n                        venture and the action is filed after the \n                        exemption becomes effective; and\n                            (ii) the conduct of the entity in making or \n                        performing a contract to carry out the joint \n                        venture shall not be deemed illegal per se but \n                        shall be judged on the basis of its \n                        reasonableness, taking into account all \n                        relevant factors affecting competition, \n                        including (but not limited to) effects on \n                        competition in properly defined, relevant \n                        research, development, product, process, and \n                        service markets (taking into consideration \n                        worldwide capacity to the extent that it may be \n                        appropriate in the circumstances).\n                    (B) An exemption under which (notwithstanding any \n                other provision of law) the antitrust laws shall not \n                apply to conduct within the scope of the joint venture \n                for a 5-year period.\n            (2) Deadline for response.--The Secretary, with the \n        concurrence of the Attorney General, shall approve or \n        disapprove the application of a health care joint venture for \n        an exemption under this subsection--\n                    (A) in the case of an exemption described in \n                paragraph (1)(A), not later than 30 days after the \n                Secretary and the Attorney General receive the joint \n                venture's application; and\n                    (B) in the case of an exemption described in \n                paragraph (1)(B), not later than 90 days after the \n                Secretary and the Attorney General receive the joint \n                venture's application.\n            (3) Providing reasons for disapproval.--If the Secretary \n        disapproves the application of a health care joint venture for \n        an exemption under this subsection, the Secretary shall provide \n        the joint venture with a statement explaining the reasons for \n        the Secretary's disapproval.\n    (b) Requirements for Approval.--For purposes of subsection (a), the \nSecretary and the Attorney General shall approve the application of a \nhealth care joint venture for an exemption under subsection (a) if--\n            (1) in the case of a joint venture seeking an exemption \n        described in subsection (a)(1)(B), the Secretary (in \n        concurrence with the Attorney General) finds that the joint \n        venture meets the criteria described in subsection (c); and\n            (2) an entity participating in the joint venture submits to \n        the Secretary, the Attorney General, and the Advisory Committee \n        an application not later than 30 days after the entity has \n        entered into a written agreement to participate in the joint \n        venture (or not later than 30 days after the date of the \n        enactment of this Act in the case of an agreement in effect as \n        of such date) that contains the following information and \n        assurances:\n                    (A) The identities of the parties to the joint \n                venture.\n                    (B) The nature, objectives, and planned activities \n                of the joint venture.\n                    (C) Assurances that the entities participating in \n                the joint venture shall notify the Secretary and the \n                Attorney General of any changes in the information \n                described in subparagraphs (A) and (B) during the \n                period for which the exemption is in effect.\n                    (D) In the case of a joint venture seeking an \n                exemption described in subsection (a)(1)(B)--\n                            (i) assurances that the entities \n                        participating in the joint venture shall submit \n                        annual reports to the Secretary and the \n                        Attorney General during the period for which \n                        the exemption is in effect on the activities of \n                        the joint venture; and\n                            (ii) any other information and assurances \n                        required by the Secretary and the Attorney \n                        General to ensure that the joint venture meets \n                        the criteria described in subsection (c).\n    (c) Criteria Described.--A health care joint venture meets the \ncriteria referred to in this subsection if the Secretary (with the \nconcurrence of the Attorney General) finds that the approval of the \njoint venture will promote each of the following goals:\n            (1) The enhancement of the quality of health care services \n        provided to individuals residing in the geographic area served \n        by the entities participating in the joint venture.\n            (2) The preservation of meaningful competition among \n        providers of health care services in such area.\n            (3) The reduction of the costs of providing health care \n        services in such area, or an increase in the efficiency of the \n        provision of such services.\n            (4) The improvement of the utilization of health care \n        services in such area.\n            (5) The elimination of costly and unnecessary duplication \n        in the delivery of health care services in such area.\n    (d) Revocation of Exemption.--\n            (1) In general.--The Secretary, in concurrence with the \n        Attorney General, may revoke an exemption provided to a health \n        care joint venture under this section if, at any time during \n        which the exemption is in effect, the Secretary finds that the \n        joint venture no longer meets any of the applicable \n        requirements for approval under subsection (b), except that the \n        Secretary may not revoke such an exemption if the failure of \n        the health care joint venture to meet such requirements is \n        merely technical in nature.\n            (2) Timing.--The revocation of an exemption under paragraph \n        (1) shall apply only to conduct of the health care joint \n        venture occurring after the date on which the Secretary revokes \n        the exemption.\n    (e) Renewal of Exemptions Providing Exemption From Antitrust \nLaws.--Upon the request of an entity participating in a health care \njoint venture for which an exemption described in subsection (a)(1)(B) \nis in effect, the Secretary, in concurrence with the Attorney General \nmay renew the exemption for an additional 5-year period if the joint \nventure continues to meet the applicable requirements for approval \nunder subsection (b).\n    (f) Withdrawal of Application.--Any party that submits an \napplication under this section may withdraw such application at any \ntime before the Secretary's and the Attorney General's response to the \napplication.\n\nSEC. 5. REQUIREMENTS RELATING TO NOTICE AND PUBLICATION OF EXEMPTIONS \n              AND RELATED INFORMATION.\n\n    (a) Publication of Approved Applications for Exemptions in Federal \nRegister.--\n            (1) In general.--With respect to each exemption for a \n        health care joint venture provided under section 4(a), the \n        Secretary (with the concurrence of the Attorney General) \n        shall--\n                    (A) prepare a notice with respect to the joint \n                venture that identifies the parties to the venture and \n                that describes the planned activities of the venture;\n                    (B) submit the notice to the entities participating \n                in the joint venture; and\n                    (C) after submitting the notice to such entities \n                (but not later than 30 days after approving the \n                application for the exemption for the joint venture), \n                publish the notice in the Federal Register.\n            (2) Effect of Publication.--An exemption provided by the \n        Secretary and the Attorney General under section 4(a) shall \n        take effect as of the date of the publication in the Federal \n        Register of the notice with respect to the exemption pursuant \n        to paragraph (1).\n    (b) Waiver of Disclosure Requirements for Information Relating to \nApplications for Exemptions.--\n            (1) In general.--All information and documentary material \n        submitted as part of an application of a health care joint \n        venture for an exemption under section 4(a), together with any \n        other information obtained by the Attorney General, the \n        Secretary, or the Advisory Committee in the course of any \n        investigation, administrative proceeding, or case with respect \n        to a potential violation of the antitrust laws by the joint \n        venture with respect to which the exemption applies, shall be \n        exempt from disclosure under section 552 of title 5, United \n        States Code, and shall not be made publicly available by any \n        agency of the United States to which such section applies, \n        except as relevant to a law enforcement investigation or in a \n        judicial or administrative proceeding in which such information \n        and material is subject to any protective order.\n            (2) Exception for information included in federal register \n        notice.--Paragraph (1) shall not apply with respect to \n        information contained in a notice published in the Federal \n        Register pursuant to subsection (a).\n    (c) Use of Information to Support or Answer Claims Under Antitrust \nLaws.--\n            (1) In general.--Except as provided in paragraph (2), the \n        fact of disclosure of conduct under an application for an \n        exemption under section 4(a) and the fact of publication of a \n        notice in the Federal Register under subsection (a) shall be \n        admissible into evidence in any judicial or administrative \n        proceeding for the sole purpose of establishing that a person \n        is entitled to the protections provided by an exemption granted \n        under section 4(a).\n            (2) Effect of rejected application.--If the Secretary and \n        the Attorney General deny, in whole or in part, an application \n        for an exemption under section 4(a), or revoke an exemption \n        under such section, neither the negative determination nor the \n        statement of reasons therefore shall be admissible into \n        evidence in any administrative or judicial proceeding for the \n        purpose of supporting or answering any claim under the \n        antitrust laws.\n\nSEC. 6. INTERAGENCY ADVISORY COMMITTEE ON COMPETITION, ANTITRUST \n              POLICY, AND HEALTH CARE.\n\n    (a) Establishment.--There is hereby established the Interagency \nAdvisory Committee on Competition, Antitrust Policy, and Health Care. \nThe Advisory Committee shall be composed of--\n            (1) the Secretary of Health and Human Services (or the \n        designee of the Secretary);\n            (2) the Attorney General (or the designee of the Attorney \n        General);\n            (3) the Director of the Office of Management and Budget (or \n        the designee of the Director); and\n            (4) a representative of the Federal Trade Commission.\n    (b) Duties.--The duties of the Advisory Committee are--\n            (1) to discuss and evaluate competition and antitrust \n        policy, and their implications with respect to the performance \n        of health care markets;\n            (2) to analyze the effectiveness of health care joint \n        ventures receiving exemptions under the program established \n        under section 4(a) in reducing the costs of and expanding \n        access to the health care services that are the subject of such \n        ventures; and\n            (3) to make such recommendations to Congress not later than \n        2 years after the date of the enactment of this Act (and at \n        such subsequent periods as the Advisory Committee considers \n        appropriate) regarding modifications to the program established \n        under section 4(a) as the Advisory Committee considers \n        appropriate, including modifications relating to the costs to \n        health care providers of obtaining an exemption for a joint \n        venture under such program."
}